Late-responding normal tissue cells benefit from high-precision radiotherapy with prolonged fraction delivery times via enhanced autophagy

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Yao, Qiwei ^a   Zheng, Rong ^a   Xie, Guozhu ^a   Liao, Guixiang ^a   Du, Shasha ^a   Ren, Chen ^a   Li, Rong ^a   Lin, Xiaoshan ^a   Hu, Daokun ^a   Yuan, Yawei ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ATM PROTEIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; REACTIVE OXYGEN METABOLITE;

AUTOPHAGY; CELL SURVIVAL; DNA DAMAGE; HUMAN; INTENSITY MODULATED RADIATION THERAPY; METABOLISM; PROCEDURES; RADIATION DOSE FRACTIONATION; RADIATION RESPONSE; RADIATION TOLERANCE; SIGNAL TRANSDUCTION; TIME FACTOR; TUMOR CELL LINE;

AMP-ACTIVATED PROTEIN KINASES; ATAXIA TELANGIECTASIA MUTATED PROTEINS; AUTOPHAGY; CELL LINE, TUMOR; CELL SURVIVAL; DNA DAMAGE; DOSE FRACTIONATION; DOSE-RESPONSE RELATIONSHIP, RADIATION; HUMANS; RADIATION TOLERANCE; RADIOTHERAPY, INTENSITY-MODULATED; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION; TIME FACTORS;

EID: 84924787598     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep09119     Document Type: Article

References (26)

1. Fang, F. M. et al. Quality of life and survival outcome for patients with nasopharyngeal carcinoma receiving three-dimensional conformal radiotherapy vs. intensity-modulated radiotherapy-a longitudinal study. Int J Radiat Oncol Biol Phys. 72, 356-364 (2008).
2. Chen, A. M. et al. Improved dosimetric and clinical outcomes with intensity-modulated radiotherapy for head-and-neck cancer of unknown primary origin. Int J Radiat Oncol Biol Phys. 79, 756-762 (2011).
3. Giraud, P. et al. [Dosimetric and clinical benefits of respiratory-gated radiotherapy for lung and breast cancers: results of the STIC 2003]. Cancer Radiother. 16, 272-281 (2012).
4. Glide-Hurst, C. K. & Chetty, I. J. Improving radiotherapy planning, delivery accuracy, and normal tissue sparing using cutting edge technologies. J Thorac Dis. 6, 303-318 (2014).
5. Mu, X., Lofroth, P. O., Karlsson, M. & Zackrisson, B. The effect of fraction time in intensity modulated radiotherapy: theoretical and experimental evaluation of an optimisation problem. Radiother Oncol. 68, 181-187 (2003).
6. Ling, C. C., Gerweck, L. E., Zaider, M. & Yorke, E. Dose-rate effects in external beam radiotherapy redux. Radiother Oncol. 95, 261-268 (2010).
7. Thames, H.D., Bentzen, S.M., Turesson, I., Overgaard, M. & Van den Bogaert, W. Time-dose factors in radiotherapy: a review of the human data. Radiother Oncol. 19, 219-235 (1990).
8. Bhandare, N., Antonelli, P. J., Morris, C. G., Malayapa, R. S. & Mendenhall, W. M. Ototoxicity after radiotherapy for head and neck tumors. Int J Radiat Oncol Biol Phys. 67, 469-479 (2007).
9. Goutham, H. V. et al. DNA double-strand break analysis by gamma-H2AX foci: a useful method for determining the overreactors to radiation-induced acute reactions among head-and-neck cancer patients. Int J Radiat Oncol Biol Phys. 84, e607-e612 (2012).
10. Klionsky, D. J. et al. Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy. 8, 445-544 (2012).
11. Duan, X., Ponomareva, L., Veeranki, S. & Choubey, D. IFI16 induction by glucose restriction in human fibroblasts contributes to autophagy through activation of the ATM/AMPK/p53 pathway. PLoS One. 6, e19532 (2011).
12. Alexander, A. et al.ATMsignals to TSC2 in the cytoplasm to regulate mTORC1 in response to ROS. Proc Natl Acad Sci U S A. 107, 4153-4158 (2010).
13. Mathew, R. et al. Autophagy suppresses tumorigenesis through elimination of p62. Cell. 137, 1062-1075 (2009).
14. Hou, J. et al. Autophagy prevents irradiation injury and maintains stemness through decreasing ROS generation in mesenchymal stem cells. Cell Death Dis. 4, e844 (2013).
15. Zheng, X. K. et al. Impact of prolonged fraction delivery times simulating IMRT on cultured nasopharyngeal carcinoma cell killing. Int J Radiat Oncol Biol Phys. 78, 1541-1547 (2010).
16. Moiseenko, V., Banath, J. P., Duzenli, C. & Olive, P. L. Effect of prolonging radiation delivery time on retention of gammaH2AX. Radiat Oncol. 3, 18 (2008).
17. Chaachouay, H. et al. Autophagy contributes to resistance of tumor cells to ionizing radiation. Radiother Oncol. 99, 287-292 (2011).
18. Liang, N. et al. ATM pathway is essential for ionizing radiation-induced autophagy. Cell Signal. 25, 2530-2539 (2013).
19. Devarajan, P. et al. Cisplatin-induced apoptosis in auditory cells: role of death receptor and mitochondrial pathways. Hear Res. 174, 45-54 (2002).
20. Pyun, J. H. et al. Epicatechin inhibits radiation-induced auditory cell death by suppression of reactive oxygen species generation. Neuroscience. 199, 410-420 (2011).
21. Zheng, X. K., Chen, L. H., Yan, X. & Wang, H. M. Impact of prolonged fraction dose-delivery time modeling intensity-modulated radiation therapy on hepatocellular carcinoma cell killing. World J Gastroenterol. 11, 1452-1456 (2005).
22. Denham, J. W. & Hauer-Jensen, M. The radiotherapeutic injury - a complex 'wound'. Radiother Oncol. 63, 129-145 (2002).
23. Kalinec, G. M., Webster, P., Lim, D. J. & Kalinec, F. A cochlear cell line as an in vitro system for drug ototoxicity screening. Audiol Neurootol. 8, 177-189 (2003).
24. Boukamp, P. et al. Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. J Cell Biol. 106, 761-771 (1988).
25. Xie, G. et al. IL-6-induced epithelial-mesenchymal transition promotes the generation of breast cancer stem-like cells analogous to mammosphere cultures. Int J Oncol. 40, 1171-1179 (2012).
26. DU S. et al. Protective effect of tanshinone IIA against radiation-induced ototoxicity in HEI-OC1 cells. Oncol Lett. 6, 901-906 (2013).